Largest ever ‘map’ of autism may hold clues for new targeted therapies
Key Points:
- Researchers at the University of California, San Francisco have created the largest protein interaction map related to autism, revealing how genetic mutations rewire brain proteins and contribute to the disorder, potentially guiding targeted therapies.
- The study, published in Science, used AI tools like AlphaFold and lab-grown brain organoids to identify over 1,800 autism-linked protein interactions, 87% of which were previously unknown, offering a new blueprint for drug discovery.
- Experts hail the research as a watershed moment for autism science, particularly for individuals with profound autism, as it shifts focus from targeting numerous genes to stabilizing disrupted protein complexes.
- While promising, translating these findings into effective treatments will take significant time and further research, with some concerns about federal research priorities potentially diverting focus from genetic and neurobiological studies.
- The new autism map may also have implications for other neuropsychiatric disorders, including schizophrenia and OCD, broadening the impact of this molecular-level understanding.